|
Index of reports
> Cases resulting in hospitalization (124)
> Cases with Blood Creatine Phosphokinase Increased (10)
Below is the selection of adverse event reports related to Zetia (Ezetimibe) that includes cases resulting in hospitalization where reactions include blood creatine phosphokinase increased.
Adverse event in 60 year old male receiving Zetia (Ezetimibe)
Reported by a physician from Japan on 2007-10-26
Patient: 60 year old male
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Hepatic Failure
Adverse event resulted in: hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Ursodiol; Phospholipids (Unspecified); Allopurinol; Pioglitazone Hydrochloride; Amlodipine Besylate
Adverse event in female receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-07-06
Patient: female, weighing 68.0 kg (149.6 pounds)
Adverse reactions / side effects: Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Diabetes Mellitus, Hypocalcaemia, Muscle Spasms
Adverse event resulted in: hospitalization
Suspect drug(s):
Lipitor
Administration route: Oral
Indication: Hypercholesterolaemia
Prednisone TAB
Zetia
Administration route: Oral
Indication: Hypercholesterolaemia
Adverse event in 42 year old male receiving Zetia (Ezetimibe)
Reported by a consumer/non-health professional from France on 2007-05-15
Patient: 42 year old male, weighing 105.0 kg (231.0 pounds)
Adverse reactions / side effects: Myalgia, Blood Creatine Phosphokinase Increased, Tachycardia, Muscular Weakness
Adverse event resulted in: hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Adverse event in 68 year old female receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-03-20
Patient: 68 year old female
Adverse reactions / side effects: Myalgia, Blood Creatine Phosphokinase Increased, Blood Creatinine Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Zetia
Administration route: Oral
Indication: Hypercholesterolaemia
Zocor
Administration route: Oral
Indication: Hypercholesterolaemia
Other drugs received by patient: Vytorin; Amiodarone Hydrochloride; Aspirin; Plavix; Xanax; Allopurinol; Synthroid; Toprol-XL; Demadex; Diovan; Lexapro
Adverse event in 51 year old male receiving Zetia (Ezetimibe)
Reported by a consumer/non-health professional from United States on 2007-01-31
Patient: 51 year old male
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Vertigo
Adverse event resulted in: hospitalization
Suspect drug(s):
Zetia (Ezetimibe)
Other drugs received by patient: Lipitor; Aspirin; Niacin; Omega-3 Marine Triglycerides
Adverse event in 52 year old male receiving Zetia (Ezetimibe)
Reported by a physician from Canada on 2007-01-24
Patient: 52 year old male
Adverse reactions / side effects: Myalgia, Blood Creatine Phosphokinase Increased, Lipoprotein (A) Increased, Drug Interaction, Acute Coronary Syndrome, Arteriosclerosis, Myopathy
Adverse event resulted in: hospitalization
Suspect drug(s):
Atorvastatin Calcium
Start date: 2000-12-01
End date: 2001-01-01
Atorvastatin Calcium
Start date: 2001-01-01
End date: 2003-11-05
Zetia
Administration route: Oral
Start date: 2003-09-24
End date: 2003-11-05
Other drugs received by patient: Atenolol; Aspirin; Clopidogrel Bisulfate; Ramipril
Adverse event in 70 year old female receiving Zetia (Ezetimibe)
Reported by a physician from Canada on 2007-01-24
Patient: 70 year old female, weighing 63.0 kg (138.6 pounds)
Adverse reactions / side effects: Abdominal Pain, Blood Creatine Phosphokinase Increased, Dyspnoea, Rhabdomyolysis, Hyperkalaemia, Hyperphosphataemia, Urinary Tract Infection, General Physical Health Deterioration, Haemoglobin Decreased, Malaise, Renal Tubular Necrosis, Muscle Spasms, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Rosuvastatin Calcium
Administration route: Oral
Start date: 2005-07-01
End date: 2006-04-01
Rosuvastatin Calcium
Administration route: Oral
Start date: 2005-03-20
End date: 2005-07-01
Zetia
Administration route: Oral
Start date: 2006-02-01
End date: 2006-04-01
Zetia
Administration route: Oral
Start date: 2006-04-01
Other drugs received by patient: Valsartan; Aspirin; Hydrochlorothiazide; Atenolol; Atenolol; Dimenhydrinate; Aspirin and Caffeine, Citrated and Codeine Phosphate; Aspirin and Caffeine, Citrated and Codeine Phosphate
Adverse event in male receiving Zetia (Ezetimibe)
Reported by a physician from Germany on 2007-01-22
Patient: male
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Blood Creatinine Increased, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Cyclosporine
Indication: Heart Transplant
Everolimus
Indication: Heart Transplant
Start date: 2006-05-01
Simvastatin
Indication: Lipid Metabolism Disorder
Zetia
Administration route: Oral
Other drugs received by patient: Mycophenolate Mofetil; Prednisolone; Heparin; Aspirin; Acetyldigoxin; Diltiazem Hydrochloride; Furosemide; Pantoprazole Sodium
Adverse event in 70 year old female receiving Zetia (Ezetimibe)
Reported by a physician from Canada on 2007-01-19
Patient: 70 year old female, weighing 63.0 kg (138.6 pounds)
Adverse reactions / side effects: Abdominal Pain, Blood Creatine Phosphokinase Increased, Dyspnoea, Rhabdomyolysis, Hyperkalaemia, Hyperphosphataemia, Urinary Tract Infection, General Physical Health Deterioration, Haemoglobin Decreased, Malaise, Renal Tubular Necrosis, Muscle Spasms, Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Rosuvastatin Calcium
Administration route: Oral
Start date: 2005-07-01
End date: 2006-04-01
Rosuvastatin Calcium
Administration route: Oral
Start date: 2005-03-20
End date: 2005-07-01
Zetia
Administration route: Oral
Start date: 2006-02-01
End date: 2006-04-01
Zetia
Administration route: Oral
Start date: 2006-04-01
Other drugs received by patient: Valsartan; Aspirin; Hydrochlorothiazide; Atenolol; Atenolol; Dimenhydrinate; Aspirin and Caffeine, Citrated and Codeine Phosphate; Aspirin and Caffeine, Citrated and Codeine Phosphate
Adverse event in 59 year old female receiving Zetia (Ezetimibe)
Reported by a physician from United States on 2007-01-17
Patient: 59 year old female, weighing 97.0 kg (213.4 pounds)
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Myoglobin Blood Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Zetia
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2006-10-11
End date: 2006-11-21
Zetia
Administration route: Oral
Indication: Blood Cholesterol Increased
Start date: 2006-10-11
End date: 2006-11-21
Other drugs received by patient: CO-Diovan; Synthroid
|
